Rituximab blocks B-cell proliferation before entry into S phase.

Resting tonsillar B cells were stimulated with SAC in the presence or absence of 2 μg/mL rituximab. Cell cycle analysis was performed at the indicated times. The percentage of cells in the different phases of the cell cycle are indicated.